Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Extended scope and efficacy of the AWT.

Introduction: Acoustic Wave Therapy is meanwhile a well established treatment method for multiple aesthetic disorders and rejuvenation treatment. It is a non-invasive treatment using focused and radial shockwaves with practically no noticeable side effects.

Materials / method: The treatment is performed with the “Sepia C-Actor” focused handpiece, “Falcon” radial handpiece and the “V-Actor” vibration handpiece. Additionally “Vacu-Actor” for the release of subcutaneous adhesions can be used.

Results: AWT equipment was significantly upgraded:
• Technical innovations include the replacement of the current “Cellactor” family by “Duolith”, AWT Edition allowing the additional use of the “Sepia FSW” focused handpiece,
doubled focused AWT pulse frequency,
vibration therapy with up to 50Hz,
“Visible Body” software,
monitors with FullHD display and PCAP TouchScreen and
“Soft-Actor” transmitter
• New indications for Mean Health can be successfully treated with our new AWT Edition equipment: Erectile dysfunction and Peyronie’s disease.
Also Women Heath indications might come in the future

Conclusion: The reported AWT innovations further increase the AWT treatment efficacy and indication range.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Storz Medical AG

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
Yes
Please specify date...: Approval process ongoing
and status : Soft-Actor transmitter: EP 17 020 149.2 and DP 20 2017 001 951.5

This work was not supported by any direct or non direct funding. It is under the author's own responsability Storz Medical AG